Initiator Pharma A/S

Informe acción OM:INIT BTA

Capitalización de mercado: SEK 350.3m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Initiator Pharma Dirección

Dirección controles de criterios 2/4

Información clave

Claus Olesen

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEO6.2yrs
Participación del CEO2.1%
Permanencia media de la dirección6.3yrs
Promedio de permanencia en la Junta Directiva5.8yrs

Actualizaciones recientes de la dirección

No hay actualizaciones

Recent updates


CEO

Claus Olesen (48 yo)

6.2yrs

Permanencia

Dr. Claus Elsborg Olesen is Chief Executive Officer at Stipe Therapeutics. He serves Chief Executive Officer at Initiator Pharma A/S since May 02, 2016 and serves as its Director since September 19, 2016 a...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Claus Olesen
Co-Founder6.2yrssin datos2.08%
DKK 7.3m
Dan Peters
Co-Founder & CTO6.5yrssin datos2.54%
DKK 8.9m
Ulf Simonsen
Co-Founderno datasin datos1.28%
DKK 4.5m
Mikael Thomsen
Co-Founder & CDOno datasin datos1.41%
DKK 4.9m
Torgeir Vaage
Chief Financial Officer6.5yrssin datos0.60%
DKK 2.1m
Allan Wehnert
Senior Vice President of Clinical and R&D Strategy & Portfolio Management1.6yrssin datossin datos
Susanne Thomsen
Head of Clin Opsno datasin datossin datos
Rene Egebro
Head of CMCno datasin datossin datos

6.3yrs

Permanencia media

58yo

Promedio de edad

Equipo directivo experimentado: INIT BTA's management team is seasoned and experienced (6.3 years average tenure).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Claus Olesen
Co-Founder5.8yrssin datos2.08%
DKK 7.3m
Gunnar Magnus Severus Persson
Chairman of the Board of Directors5.8yrssin datos0.52%
DKK 1.8m
Henrik Moltke
Director5.8yrssin datos0.24%
DKK 844.9k
Irwin Goldstein
Member of Scientific & Clinical Advisory Board1.6yrssin datossin datos
Annette Colin
Director1.5yrssin datos0.015%
DKK 52.3k
Peter Holm
Director5.8yrssin datossin datos
Sue Goldstein
Member of Scientific & Clinical Advisory Board1.6yrssin datossin datos

5.8yrs

Permanencia media

57yo

Promedio de edad

Junta con experiencia: INIT BTA's board of directors are considered experienced (5.8 years average tenure).